“Results of the eValuation of ERTugliflozin EffIcacy and Safety CardioVascular Outcomes Trial (VERTIS-CV)” closes out the ADA Virtual 80th Scientific Sessions. Richard E. Pratley, MD, (pictured) provided an overview of the study rationale and design. Watch the session on ADA2020.org.
Happening now: Results of VERTIS-CV are presented in the final session of #ADA2020
